Related Experiment Video
Updated: May 21, 2026

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2
Chen-Wen Chen1, Qian-Bo Chen, Qing Ouyang
1Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China. 1002153376@qq.com.
Abstract:
Activated microglia exerts both beneficial and deleterious effects on neurons, but the signaling mechanism controlling these distinct responses remain unclear. We demonstrated that treatment of microglial cultures with the PAR-2 agonist, 2-Furoyl-LIGRLO-NH2, evoked early transient release of BDNF, while sustained PAR-2 stimulation evoked the delayed release of inflammatory cytokines (IL-1 β and TNF-α) and nitric oxide. Culture medium harvested during the early phase (at 1 h) of microglial activation induced by 2-Furoyl-LIGRLO-NH2 (microglial conditioned medium, MCM) had no deleterious effects on cultured neurons, while MCM harvested during the late phase (at 72 h) promoted DNA fragmentation and apoptosis as indicated by TUNEL and annexin/PI staining. Blockade of PAR-1 during the early phase of PAR-2 stimulation enhanced BDNF release (by 11%, small but significant) while a PAR-1 agonist added during the late phase (24 h after 2-Furoyl-LIGRLO-NH2 addition) suppressed the release of cytokines and NO. The neuroprotective and neurotoxic effects of activated microglial exhibit distinct temporal profiles that are regulated by PAR-1 and PAR-2 stimulation. It may be possible to facilitate neuronal recovery and repair by appropriately timed stimulation and inhibition of microglial PAR-1 and PAR-2 receptors.
Insights
Activated microglia
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia's dual role in neuronal health and damage is incompletely understood.
- Signaling pathways governing microglial beneficial vs. detrimental actions require elucidation.
Purpose of the Study:
- To investigate the temporal signaling mechanisms of microglial activation by Protease-Activated Receptor 2 (PAR-2).
- To determine the impact of PAR-2 stimulation timing on neuronal outcomes.
- To explore the modulatory roles of Protease-Activated Receptor 1 (PAR-1) in microglial responses.
Main Methods:
- Primary microglial cultures were stimulated with a PAR-2 agonist (2-Furoyl-LIGRLO-NH2).
- Microglial conditioned medium (MCM) from early (1h) and late (72h) phases was applied to cultured neurons.
- PAR-1 blockade and agonism were employed during different phases of PAR-2 stimulation.
- Neuronal apoptosis was assessed using TUNEL and annexin/PI staining.
Main Results:
- Early PAR-2 stimulation transiently released Brain-Derived Neurotrophic Factor (BDNF).
- Sustained PAR-2 stimulation led to delayed release of inflammatory cytokines (IL-1β, TNF-α) and nitric oxide (NO).
- Early-phase MCM was neuroprotective, while late-phase MCM induced neuronal apoptosis.
- PAR-1 blockade enhanced BDNF release; PAR-1 agonism suppressed late-phase cytokine/NO release.
Conclusions:
- Neuroprotective and neurotoxic microglial effects have distinct temporal profiles.
- PAR-1 and PAR-2 signaling critically regulate these temporal responses.
- Targeted modulation of microglial PAR-1 and PAR-2 offers potential for promoting neuronal repair.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Encephalitis ll: Pathophysiology

